NDC 58264-0381

G-18

Fraxinus Excelsior Leaf

G-18 is a Sublingual Solution in the Human Otc Drug category. It is labeled and distributed by Dna Labs, Inc.. The primary component is Fraxinus Excelsior Leaf.

• Product ID: 58264-0381_2851e387-496c-4a13-9fe5-9364309673fd
• NDC: 58264-0381
• Product Type: Human Otc Drug
• Proprietary Name: G-18
• Generic Name: Fraxinus Excelsior Leaf
• Dosage Form: Solution
• Route of Administration: SUBLINGUAL
• Marketing Start Date: 1990-01-01
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: DNA Labs, Inc.
• Substance Name: FRAXINUS EXCELSIOR LEAF
• Active Ingredient Strength: 1 [hp_X]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 58264-0381-2

59.14 mL in 1 BOTTLE, GLASS (58264-0381-2)

• Marketing Start Date: 1990-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 58264-0381-2 [58264038102]

G-18 SOLUTION

• Marketing Category: UNAPPROVED HOMEOPATHIC
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 1990-01-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
FRAXINUS EXCELSIOR LEAF	1 [hp_X]/mL

OpenFDA Data

• SPL SET ID: 8f21c2a7-825c-44de-9341-8a66b2c0e08a
• Manufacturer:
  • DNA Labs, Inc.
• UNII:
  • RC38362Q7M